Business Context and Reporting Period
This Form 8-K filing by Neuralstem, Inc. (not Palisade Bio, Inc.) reports on the results of the 2018 Annual Meeting of Stockholders held on June 11, 2018. The report was filed on June 14, 2018.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding corporate governance events rather than a financial statement.
Material Changes and Voting Results
The filing details the outcomes of two proposals voted on by stockholders of record as of April 24, 2018. A total of 15,160,014 shares were outstanding, with 10,502,236 shares represented at the meeting, constituting a quorum.
- Proposal 1 (Election of Class I Directors):
- Scott Ogilvie: Elected with 1,635,135 votes for, 271,609 votes withheld, and 8,595,492 non-votes.
- Sandford Smith: Elected with 1,487,044 votes for, 419,700 votes withheld, and 8,595,492 non-votes.
- Proposal 2 (Ratification of Auditors):
- Dixon Hughes Goodman was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2018.
- Votes: 9,743,284 for, 88,229 against, 669,723 abstentions, and 0 non-votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on financial outlook, specific risks, contingencies, or unusual items. The document is limited to the disclosure of voting results.
Key Facts for Investor Verification
- Verify the company name is Neuralstem, Inc., as the input metadata referenced Palisade Bio, Inc.
- Confirm the election of Scott Ogilvie and Sandford Smith to the Board of Directors for a three-year term.
- Note the significant number of non-votes (8,595,492) on the director election proposals, indicating broker non-votes or abstentions on that specific item.
- Confirm the ratification of Dixon Hughes Goodman as the external auditor.